Infliximab in Crohn's Disease: First Anniversary Clinical Experience

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

1997 • 3,152 citations

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

1999 • 2,656 citations

Physicians Desk Reference

1994 • 2,653 citations

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

1994 • 1,695 citations

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1998 • 1,642 citations

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

1999 • 1,107 citations

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)

1995 • 1,103 citations

Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

1994 • 632 citations

1995 Physicians' Desk Reference

1995 • 565 citations

Inflammatory Bowel Disease

1992 • 252 citations

The Cost of Hospitalization in Crohn's Disease

2000 • 143 citations

Inflammatory Bowel Disease

1992 • 117 citations

Infliximab approved for use in Crohn's disease: A report on the fda gi advisory committee conference

1998 • 105 citations

Infliximab Approved for Use in Crohnʼs Disease: A Report on the FDA GI Advisory Committee Conference

1998 • 97 citations

ANTI-TUMOR NECROSIS FACTOR-α MONOCLONAL ANTIBODY THERAPY FOR RHEUMATOID ARTHRITIS

1998 • 74 citations

Advances in the management of Crohn's disease: economic and clinical potential of infliximab

1998 • 59 citations

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor ? therapy in rheumatoid arthritis

1998 • 12 citations